Abstract
As little as 10 years ago, the assertion that growth hormone (GH) was important for humans past the time of adolescence and closure of the bony epiphyses had little or no credence among endocrinologists. This was because the physiologic action of GH was “known” to be the growth of long bones, while its actions on other (soft) tissues was appreciated mainly as a pathological phenomenon in acromegaly. Also, it was widely accepted that adult patients with monomeric GH deficiency or panhypopituitarism treated with thyroid, adrenal, and sex hormones did relatively well. Nonetheless, physicians treating significant numbers of such patients noted that many of them complained of a lack of energy and strength, low levels of libido, and a “plump” physique with fat depots apparently resistant to exercise and dieting. The relationship of these problems to GH deficiency remained moot because the supply of human pituitary extract GH was only sufficient to treat short stature in children.
Keywords
- Growth Hormone
- Growth Hormone Deficiency
- Growth Hormone Level
- Growth Hormone Treatment
- Growth Hormone Release Hormone
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797–803.
Christiansen JS, Jørgensen JOL. Beneficial effects of GH replacement therapy in adults. Acta Endocrinol (Copenh) 1991;125:7–13.
Jørgensen JOL, Blum WF, Møller N, Ranke MB, Christiansen JS. Short-term changes in serum insulin-like growth factors (IGF) and binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 1991;72:582–7.
Merola B, Colao A, et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993;77:1658–61.
Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH) deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993;77:1671–6.
Jørgensen JOL, Thuesen L, Ingemann-Hansen T, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1:1221–5.
Cuneo RC, Salomon F, Wiles CM, Sönksen PH. Skeletal muscle performance in adults with growth hormone deficiency. Horm Metab Res 1990; 33(suppl 4):55–60.
Bonnet F, Lodeweyckx MV, Eeckels R, Malvaux P. Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone. Pediatr Res 1974;8:800–5.
Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285–8.
Crist DM, Peake GT, Mackinnon LT, Sibbit WL, Kraner JC. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism 1987;36:1115–7.
Jorgensen JOL, Pedersen SA, Thuesen L, et al. Long-term growth hormone treatment in the growth hormone deficient adults. Acta Endocrinol (Copenh) 1991;125:449–53.
Crist DM, Peake GT, Loftfield RB, Kraner JC, Egan PA. Supplemental growth hormone alters body composition, muscle protein metabolism and serum lipids in fit adult: characterization of dose-dependent and dose-recovery effects. Mech Ageing Dev 1991;58:191–205.
Cuneo R, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone-deficient adults; II. Effects on exercise performance. J Appl Physiol 1991;70:695–700.
Van der Veen E, Netelenbos JC. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm Res 1990;33(suppl 4):65–8.
Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Al E. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991;81:587–92.
McGauley GA, Cuneo RC, Salomon F, Sönksen PH. Psychological wellbeing before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 1990;33(suppl 4):52–4.
Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970;19:653–63.
Forbes G. The adult decline in lean body mass. Hum Biol 1976;48:161–73.
Chon S, Vartsky D, Yasamura S. Compartmental body composition based on total body nitrogen, potassium and calcium. Am J Physiol 1980;239:E5524–30.
Shimokata H, Tobin JD, Muller DC, Elahi D, Coon Pi, Andres R. Studies in the distribution of body fat; I. Effects of age, sex, and obesity. J Gerontol 1989;44:M67–73.
Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S. Relationship of fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 1983;102:621–7.
Heiss G, Tamir I, Davis CE, et al. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation 1980;61:302–15.
Lakatta E, Goldberg AP, Fleg JL. Reduced cardiovascular and metabolic reserve in older persons: disuse, disease, aging? In: Lipschitz DA, Chernoff R, eds. Nutrition and aging II: health promotion and disease prevention in the elderly. New York: Raven Press, 1988.
Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2max in older men. J Appl Physiol 1990;68:329–33.
Makinodan T, Kirokawa K. Normal aging and the immune system. In: Johnson HA, ed. Relations between normal aging and disease. New York: Raven Press, 1985:117–32.
Gupta S, Fikrig SM, Noval MS. Immunological studies in patients with isolated growth hormone deficiency. Clin Exp Immunol 1983;19:87–90.
Abbassi V, Bellanti JA. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with growth hormone. Pediatr Res 1985;19:299–301.
Kelley KW. The role of growth hormone in modulation of the immune response. Ann NY Acad Sci 1990;594:95–103.
Prinz PN, Weitzman ED, Cunningham GR, Karacan I. Plasma growth hormone during sleep in young and aged men. J Gerontol 1983;38:519–24.
Zadik Z, Chalew SA, McCarter RJ, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985;60:513–6.
Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on 24-hour profile of growth hormone secretion in men: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51–8.
Kelijman M. Age-related alterations of the growth hormone/insulin-likegrowth-factor I axis. J Am Geriatr Soc 1991;39:295–307.
Rudman D, Vintner MH, Rogers CM, Lubin MF, Fleming GH, Raymond PB. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981;67:1361–9.
Vermeulen A. Nyctohemoral growth hormone profiles in young and aged men: correlations with somatomedin-C levels. J Clin Endocrinol Metab 1987; 64:884–8.
Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081–8.
Shibasaki T, Shizume K, Nakahara M, et al. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 1984;58:212–4.
Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ M. Effects of sex and age on growth hormone response to growth hormone releasing hormone in healthy individuals. J Clin Endocrinol Metab 1987;65: 535–40.
Pavlov EP, Harman SM, Merriam GR, Gelato MC, Blackman MR. Responses of growth hormone and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986;62:595–600.
Clemmons D, Van Wyk JJ. Somatomedin C in blood. J Clin Endocrinol Metab 1984;13:113–43.
Rudman D, Nagraj HS, Mattson D, Erve RR, Rudman IW. Hyposomatomedinemia in the nursing home patient. J Am Geriatr Soc 1986;34:42730.
Tobin J, Blackman MR, Harman SM, Sherman S. Serum insulin-like growth factor I (IGF-I) levels in normal women and men: relationships to age and body composition [Abstract]. Gerontologist 1992;32:92.
Florini JR, Prinz PN, Vitrello MV, Hintz RL. Somatomedin-C levels in healthy young and old men: relationships to peak and 24-hour integrated levels of growth hormone. J Gerontol 1985;40:2–7.
Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Twice daily subcutaneous injections of GHRH 1–29 reverse the decreased GH and IGF-1 levels in old men. J Clin Endocrinol Metab 1992;75:530–5.
Rudman D, Feller AG, Nagraj HS, et al. Effect of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1–6.
Binnerts A, Wilson JHP, Lamberts SWJ. The effects of human growth hormone administration in elderly adults with recent weight loss. J Clin Endocrinol Metab 1988;67:1312–6.
Ponting GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition on growth hormone. Lancet 1988;2:438–9.
Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 1991;39: 235–40.
Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519–27.
Corpas E, Harman MS, Piñeyro MA, Roberson R, Blackman MR. Continuous subcutaneous infusions of GHRH 1–44 for 14 days increase GH and IGF-I levels in old men. J Clin Endocrinol Metab 1993;76:134–8.
Hagberg JM, Seals DR, Yerg JE, et al. Metabolic responses to exercise in young and old athletes and sedentary men. J Appl Physiol 1988;65:900–8.
Yarasheski KE, Campbell JA, Rennie MJ, Holloszy JO, Bier DM. Effect of strength training and growth hormone administration on whole body and skeletal muscle leucine metabolism. Med Sci Sports Exerc 1990;22:505A.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this paper
Cite this paper
Harman, S.M., Blackman, M.R. (1995). Growth Hormone and Aging: A Brief Review. In: Blackman, M.R., Roth, J., Harman, S.M., Shapiro, J.R. (eds) GHRH, GH, and IGF-I. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-0807-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0807-5_22
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6908-3
Online ISBN: 978-1-4612-0807-5
eBook Packages: Springer Book Archive